Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-armstrong

Viral Immunology

Volumn 21, Issue 4, 2008, Pages 425-433

  Hofer, Markus J ^a   Carter, Sally L ^a   Müller, Marcus ^a,b   Campbell, Iain L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIGAND; PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; BRAIN; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROGLIA; MONONUCLEAR CELL; MORTALITY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; VIRUS INFECTION; VIRUS MENINGITIS; VIRUS STRAIN;

ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CHEMOKINES, CXC; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORTALITY; RECEPTORS, CXCR3;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

EID: 58149268001     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0057     Document Type: Article

References (45)

1. Allan JE, and Doherty PC: Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis. Cell Immunol 1985;90:401-407.
2. Asensio VC, and Campbell IL: Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 1997;71:7832-7840.
3. Asensio VC, Lassmann S, Pagenstecher A, Steffensen SC, Henriksen SJ, and Campbell IL: C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol 1999;154:1181-1191.
4. Asensio VC, Maier J, Milner R, et al.: Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 2001;75:7067-7077.
5. Barton LL, and Mets MB: Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 2001;33:370-374.
6. Buchmeier MJ, Welsh RM, Dutko FJ, and Oldstone MB: The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
7. Carter SL, Muller M, Manders PM, and Campbell IL: Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 2007;55:1728-1739.
8. Charo IF, and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-621.
9. Christensen JE, de Lemos C, Moos T, Christensen JP, and Thomsen AR: CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J Immunol 2006;176:4235-4243.
10. Christensen JE, Nansen A, Moos T, Lu B, Gerard C, Christensen JP, and Thomsen AR: Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J Neurosci 2004;24:4849-4858.
11. Cole GA, Nathanson N, and Prendergast RA: Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 1972;238:335-337.
12. Cole KE, Strick CA, Paradis TJ, et al.: Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998;187:2009-2021.
13. Doherty PC, Allan W, Eichelberger M, and Carding SR: Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992;10:123-151.
14. Dutko FJ, and Oldstone MB: Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J Gen Virol 1983;64(Pt 8):1689-1698.
15. Farber JM: A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 1990;87:5238-5242.
16. Hancock WW, Lu B, Gao W, et al.: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000;192:1515-1520.
17. Hiroi M, and Ohmori Y: Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Biochem J 2003;376:393-402.
18. Hsieh MF, Lai SL, Chen JP, et al.: Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol 2006;177:1855-1863.
19. Kang SS, and McGavern DB: Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci 2008;13:4529-4543.
20. Kim CH, Johnston B, and Butcher EC: Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002;100:11-16.
21. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, and Diamond MS: Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005;79:11457-11466.
22. Liu L, Callahan MK, Huang D, and Ransohoff RM: Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 2005;68:149-181.
23. Liu MT, Armstrong D, Hamilton TA, and Lane TE: Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001;166:1790-1795.
24. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, and Lane TE: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000;165:2327-2330.
25. Loetscher M, Gerber B, Loetscher P, et al.: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-969.
26. Loetscher P, Pellegrino A, Gong JH, et al.: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001;276:2986-2991.
27. Luster AD, and Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987;166:1084-1097.
28. Nansen A, Christensen JP, Ropke C, Marker O, Scheynius A, and Thomsen AR: Role of interferon-gamma in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-gamma knock-out mice. J Neuroimmunol 1998;86:202-212.
29. Nansen A, Marker O, Bartholdy C, and Thomsen AR: CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection. Eur J Immunol 2000;30:1797-1806.
30. Ohmori Y, Fukumoto S, and Hamilton TA: Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J Immunol 1995;155:3593-3600.
31. Ohmori Y, and Hamilton TA: Cell type and stimulus specific regulation of chemokine gene expression. Biochem Biophys Res Commun 1994;198:590-596.
32. Ohmori Y, Tebo J, Nedospasov S, and Hamilton TA: Kappa B binding activity in a murine macrophage-like cell line. Sequence-specific differences in kappa B binding and transcriptional activation functions. J Biol Chem 1994;269:17684-17690.
33. Ousman SS, and Campbell IL: Regulation of murine interferon regulatory factor gene expression in the central nervous system determined by multiprobe RNase protection assay. Methods Mol Med 2005;116:115-134.
34. Ousman SS, Wang J, and Campbell IL: Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 2005;79:7514-7527.
35. Padovan E, Spagnoli GC, Ferrantini M, and Heberer M: IFNalpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 2002;71:669-676.
36. Parlato S, Santini SM, Lapenta C, et al.: Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 2001;98:3022-3029.
37. Qin S, Rottman JB, Myers P, et al.: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.
38. Rani, M. R., G. R. Foster, S. Leung, D. Leaman, G. R. Stark and R. M. Ransohoff, 1996, Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 271: 22878-84.
39. Rot A, and von Andrian UH: Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928.
40. Sandberg K, Eloranta ML, and Campbell IL: Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J Virol 1994;68:7358-7366.
41. Sandberg K, Kemper P, Stalder A, Zhang J, Hobbs MV, Whitton JL, and Campbell IL: Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. J Immunol 1994;153:220-231.
42. Schwendemann G, Lohler J, and Lehmann-Grube F: Evidence for cytotoxic T-lymphocyte-target cell interaction in brains of mice infected intracerebrally with lymphocytic choriomeningitis virus. Acta Neuropathol 1983;61:183-195.
43. Stiles LN, Hosking MP, Edwards RA, Strieter RM, and Lane TE: Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol 2006;36:613-622.
44. Tensen CP, Flier J, Rampersad SS, Sampat-Sardjoepersad S, Scheper RJ, Boorsma DM, and Willemze R: Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. Biochim Biophys Acta 1999;1446:167-172.
45. Zhang B, Chan YK, Lu B, Diamond MS, and Klein RS: CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 2008;180:2641-2649.